THURSDAY, Dec. 15, 2022 (HealthDay News) — Quitting alcohol can help reduce complications of liver cirrhosis, even in patients who have advanced disease. It can also help them live longer, new research shows. “Our results clearly show that all patients with alcohol-related liver cirrhosis who maintain sustained abstinence from alcoholContinue Reading

WEDNESDAY, Dec. 14, 2022 (HealthDay News) — Bees, in their role as master pollinators, increase crop yields, leading to more production of healthy fruits, vegetables and nuts. But new research claims that the challenges these important insects face from changes in land use, harmful pesticides and climate change is affectingContinue Reading

MONDAY, Sept. 26, 2022 (HealthDay News) — People who work in manufacturing, welding and chemical operations and are exposed to hazardous chemicals may face a higher risk of developing amyotrophic lateral sclerosis (ALS), a new study found. “This study shows that certain occupational settings and exposures increase one’s chances ofContinue Reading

FRIDAY, Sept. 23, 2022 (HealthDay News) — People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows. The medication, tofersen, benefited patients with mutations of the gene SOD1. These mutations create a misfolded version of a protein, which leadsContinue Reading

THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for ALS (amyotrophic lateral sclerosis). The FDA is not obligated to follow its advisors’ recommendations, though it usually does. Wednesday’s vote was 7-2Continue Reading